On 15 May, Chinese was telephonyed for 14 days in connection with the disclosure of the annual report. The annual report shows that the premiums for services and market operations in the marketing costs of dynamite drugs in 2022 amounted to $1,117 million, representing 30 per cent of the company’s business income in 2022. (b) Whether the payment arrangement is commercially reasonable and whether there is any control over the holding of funds through the service provider; At the same time, the...